86 related articles for article (PubMed ID: 2284311)
1. Some studies on the preservation of indometacin suspensions intended for ophthalmic use.
Vulovic N; Primorac M; Stupar M; Brown MW; Ford JL
Pharmazie; 1990 Sep; 45(9):678-9. PubMed ID: 2284311
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of ophthalmic suspensions using surface tension.
Yasueda S; Inada K; Matsuhisa K; Terayama H; Ohtori A
Eur J Pharm Biopharm; 2004 Mar; 57(2):377-82. PubMed ID: 15018999
[TBL] [Abstract][Full Text] [Related]
3. The assay of benzalkonium chloride in pilocarpine, hypromellose and polyvinyl alcohol ophthalmic drops by second-order derivative ultraviolet spectrophotometry.
Parkin JE
J Pharm Biomed Anal; 1993 Jul; 11(7):609-11. PubMed ID: 8399536
[No Abstract] [Full Text] [Related]
4. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing cefazolin.
Kodym A; Zawisza T; Buźka K; Kukuła H
Acta Pol Pharm; 2006; 63(3):225-34. PubMed ID: 20085229
[TBL] [Abstract][Full Text] [Related]
5. Incompatibility of indometacin and benzalkonium in eye drops due to ion-pair formation.
Dreijer-van der Glas SM; Bult A
Pharm Weekbl Sci; 1987 Feb; 9(1):29-32. PubMed ID: 3562200
[TBL] [Abstract][Full Text] [Related]
6. Rapid determination of total benzalkonium chloride content in ophthalmic formulation.
Labranche LP; Dumont SN; Levesque S; Carrier A
J Pharm Biomed Anal; 2007 Feb; 43(3):989-93. PubMed ID: 17045769
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ophthalmic vehicles using fluorescein uptake technique.
Capella JA; Schaefer IM
Eye Ear Nose Throat Mon; 1974 Jan; 53(1):23-5. PubMed ID: 4208067
[No Abstract] [Full Text] [Related]
8. Determination of benzalkonium chloride in aqueous ophthalmic preparations by high-performance liquid chromatography.
Gomez-Gomar A; Gonzalez-Aubert MM; Garces-Torrents J; Costa-Segarra J
J Pharm Biomed Anal; 1990; 8(8-12):871-6. PubMed ID: 2100635
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic determination of benzalkonium and naphazoline or tetrahydrozoline in nasal and ophthalmic solutions.
Santoni G; Medica A; Gratteri P; Furlanetto S; Pinzauti S
Farmaco; 1994 Nov; 40(11):751-4. PubMed ID: 7530451
[TBL] [Abstract][Full Text] [Related]
10. Stability of latanoprost in an ophthalmic lipid emulsion using polyvinyl alcohol.
Sakai Y; Yasueda S; Ohtori A
Int J Pharm; 2005 Nov; 305(1-2):176-9. PubMed ID: 16207517
[TBL] [Abstract][Full Text] [Related]
11. [A sensitive test for indomethacin in oily ophthalmic drops and other preparations].
Papke E
Pharmazie; 1987 Oct; 42(10):696-7. PubMed ID: 3438323
[No Abstract] [Full Text] [Related]
12. A safety test for contact lens wetting solutions. Evaluation of commercially available solutions.
Rucker I; Kettrey R; Bach F; Zeleznick L
Ann Ophthalmol; 1972 Nov; 4(11):1000-6. PubMed ID: 4119929
[No Abstract] [Full Text] [Related]
13. [Clinical evaluation of betaxolol in ophthalmic suspension with or without preservative agent in patients with glaucoma or ocular hypertension].
Denis P; Demailly P; Saraux H
J Fr Ophtalmol; 1993; 16(5):297-303. PubMed ID: 8331248
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
Bozdağ S; Gümüş K; Gümüş O; Unlü N
Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
[TBL] [Abstract][Full Text] [Related]
15. [On the antimicrobial activity of benzalkonium chloride in potential contact lens fluids].
Jira T; Panzig B; Pohloudek-Fabini R
Pharmazie; 1982 Aug; 37(8):587-90. PubMed ID: 7146068
[TBL] [Abstract][Full Text] [Related]
16. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
Kodym A; Marcinkowski A; Kukuła H
Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
[TBL] [Abstract][Full Text] [Related]
17. The effect of low density polyethylene containers on some hospital-manufactured eyedrop formulations. II. Inhibition of the sorption of phenylmercuric acetate.
Aspinall JE; Duffy TD; Taylor CG
J Clin Hosp Pharm; 1983 Sep; 8(3):233-40. PubMed ID: 6630562
[TBL] [Abstract][Full Text] [Related]
18. Characterization and drug release investigation of amorphous drug-hydroxypropyl methylcellulose composites made via supercritical carbon dioxide assisted impregnation.
Gong K; Rehman IU; Darr JA
J Pharm Biomed Anal; 2008 Dec; 48(4):1112-9. PubMed ID: 18922658
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic investigation of the interaction of phenylmercuric nitrate and sodium metabisulphite in eye drop formulations.
Parkin JE
J Chromatogr; 1990 Jul; 511():233-42. PubMed ID: 2211913
[TBL] [Abstract][Full Text] [Related]
20. Ocular retention of artificial tear solutions. Comparison of hydroxypropyl methylcellulose and polyvinyl alcohol vehicles using an argyrol marker.
Bach FC; Adam JB; McWhirter HC; Johnson JE
Ann Ophthalmol; 1972 Feb; 4(2):116-9. PubMed ID: 4110130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
